What are the side effects of taking montelukast?
Advertisement
- Body aches or pain.
- difficulty in breathing.
- dryness or soreness of the throat.
- headache.
- pain, redness, or swelling in the ear.
- stomach pain.
- tender, swollen glands in neck.
- trouble in swallowing.
What kind of pill is 392?
PGO06040: This medicine is a brown, round, film-coated, tablet imprinted with “I-2”. WAL03920: This medicine is a orange, round, film-coated, tablet imprinted with “44 392”.
What is montelukast used to treat?
Montelukast is used to treat and prevent asthma. It will decrease the symptoms and the number of acute asthma attacks. However, this medicine should not be used to relieve an asthma attack that has already started.
What drugs should not be taken with montelukast?
Allergy to aspirin or. Allergy to nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, celecoxib, ibuprofen, naproxen, Advil®, Aleve®, or Motrin®)—Continue to avoid aspirin or NSAIDs while taking this medicine.
Does montelukast cause anxiety?
Those taking montelukast who exhibit mood changing behaviors should immediately report symptoms to a healthcare provider. These can include bad or vivid dreams, depression, disorientation or confusion, feeling anxious, hallucinations, irritability, restlessness, stuttering, and uncontrolled muscle movements.
How long does it take for ibuprofen to wear off?
It can take up to 24 hours to completely rid your system of ibuprofen, even though its effects generally last about 4 to 6 hours. According to the prescribing information, the ibuprofen half-life is about two hours. In case of an ibuprofen overdose, call 911 or Poison Control at 800-222-1222. What does ibuprofen do?
Does montelukast make you sleepy?
Sleep problems have occurred in people taking montelukast oral tablets. They weren’t reported during clinical studies of the drug, but problems with sleep have been reported since the drug was approved. Sleep problems may include: insomnia (trouble falling asleep or staying asleep)
Can montelukast help with Covid?
Our findings suggest that montelukast associates with a reduction in clinical deterioration for COVID-19 confirmed patients as measured on the COVID-19 Ordinal Scale.